The association between the use of non-steroidal anti-inflammatory drugs and atrial fibrillation: A nationwide case-control study

International Journal of Cardiology

Volumn 168, Issue 1, 2013, Pages 312-316

  Chao, Tze Fan ^a,b   Liu, Chia Jen ^a   Chen, Su Jung ^a   Wang, Kang Ling ^a,b   Lin, Yenn Jiang ^a,b   Chang, Shih Lin ^a,b   Lo, Li Wei ^a,b   Hu, Yu Feng ^a,b   Tuan, Ta Chuan ^a,b   Wu, Tsu Juey ^b,c   Chen, Tzeng Ji ^a   Tsao, Hsuan Ming ^b   Chen, Shih Ann ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Atrial fibrillation; COX2 inhibitors; NSAIDs

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ETODOLAC; FENOPROFEN; FLUFENAMIC ACID; FLURBIPROFEN; IBUPROFEN; INDOMETACIN; KETOPROFEN; KETOROLAC; MECLOFENAMIC ACID; MEFENAMIC ACID; MELOXICAM; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; ROFECOXIB; STEROID; SULINDAC; TENOXICAM; TOLFENAMIC ACID;

AGED; ARTICLE; ASTHMA; BRAIN ISCHEMIA; CASE CONTROL STUDY; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEADACHE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; HYPERTHYROIDISM; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL DISEASE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFECTION; RISK FACTOR; SLEEP DISORDERED BREATHING;

ATRIAL FIBRILLATION; COX2 INHIBITORS; NSAIDS;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ATRIAL FIBRILLATION; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; TAIWAN;

EID: 84883827162     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.09.058     Document Type: Article

References (21)

1. V. Fuster, L.E. Ryden, and D.S. Cannom ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Circulation 114 2006 e257 e354
2. A.S. Go, E.M. Hylek, and K.A. Phillips Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study JAMA 285 2001 2370 2375
3. W.M. Feinberg, J.L. Blackshear, A. Laupacis, R. Kronmal, and R.G. Hart Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications Arch Intern Med 155 1995 469 473
4. P.A. Wolf, R.D. Abbott, and W.B. Kannel Atrial fibrillation as an independent risk factor for stroke: the Framingham Study Stroke 22 1991 983 988
5. C.J. Boos, R.A. Anderson, and G.Y. Lip Is atrial fibrillation an inflammatory disorder? Eur Heart J 27 2006 136 149
6. T. Liu, G. Li, L. Li, and P. Korantzopoulos Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis J Am Coll Cardiol 49 2007 1642 1648
7. L. Laine The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors Semin Arthritis Rheum 32 2002 25 32
8. R. De Caterina, A. Ruigomez, and L.A. Rodriguez Long-term use of anti-inflammatory drugs and risk of atrial fibrillation Arch Intern Med 170 2010 1450 1455
9. M. Schmidt, C.F. Christiansen, F. Mehnert, K.J. Rothman, and H.T. Sorensen Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study BMJ 343 2011 d3450
10. S. Wacholder, J.K. McLaughlin, D.T. Silverman, and J.S. Mandel Selection of controls in case-control studies. I. Principles Am J Epidemiol 135 1992 1019 1028
11. T.T. Issac, H. Dokainish, and N.M. Lakkis Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data J Am Coll Cardiol 50 2007 2021 2028
12. M.K. Chung, D.O. Martin, and D. Sprecher C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation Circulation 104 2001 2886 2891
13. J.L. Anderson, C.A. Allen Maycock, and D.L. Lappe Frequency of elevation of C-reactive protein in atrial fibrillation Am J Cardiol 94 2004 1255 1259
14. Y.J. Lin, H.M. Tsao, and S.L. Chang Prognostic implications of the high-sensitive C-reactive protein in the catheter ablation of atrial fibrillation Am J Cardiol 105 2010 495 501
15. A. Whelton Renal aspects of treatment with conventional nonsteroidal anti-inflammatory drugs versus cyclooxygenase-2-specific inhibitors Am J Med 110 Suppl. 3A 2001 33S 42S
16. A. Chiolero, G. Wurzner, and M. Burnier Selective inhibitors of type 2 cyclooxygenase: less renal effects than the classical non-steroidal anti-inflammatory agents Nephrologie 21 2000 425 430
17. G.B. Appel COX-2 inhibitors and the kidney Clin Exp Rheumatol 19 2001 S37 S40
18. M.D. Breyer, C. Hao, and Z. Qi Cyclooxygenase-2 selective inhibitors and the kidney Curr Opin Crit Care 7 2001 393 400
19. K. Daham, W.L. Song, and J.A. Lawson Effects of celecoxib on major prostaglandins in asthma Clin Exp Allergy 41 2011 36 45
20. M. Haissaguerre, P. Jais, and D.C. Shah Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins N Engl J Med 339 1998 659 666
21. S.A. Chen, M.H. Hsieh, and C.T. Tai Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation Circulation 100 1999 1879 1886